|
|
HOT TOPICS IN VIRAL HEPATITIS: Issue 13, 2009
Intravenous drug users and chronic hepatitis C
Risks and benefits of treating chronic hepatitis C virus infection in injecting drug users
Graham R. Foster
Correspondence to:
Graham R. Foster - FRCP, PhD Professor The Liver Unit, Digestive Diseases Clinical Academic Unit Queen Mary University of London, Barts and The London School of Medicine The Royal London Hospital London, UK E-mail: g.r.foster@qmul.ac.uk
Summary
- BENEFITS OF ANTIVIRAL THERAPY
- RISKS OF ANTIVIRAL THERAPY
- MODELS OF CARE
- REFERENCES
If you have a Username and Password, you may already access to this article. Please login below.
If you do not have a Username and Password, click the "Register" button below to purchase this article.
|
 |
|
|
|
No additional articles by this author(s) are available in our Series.
|
|
| |
|
|
|